Global Cancer/Tumor Profiling Market to Generate USD 31.67 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
August 01, 2022 07:16 ET
|
Next Move Strategy Consulting
New York, Aug. 01, 2022 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the global cancer/tumor profiling market generated USD 11.10 billion in 2021, and is...
Cornerstone Pharmaceuticals Strengthens Scientific Advisory Board with the Appointment of Distinguished Scholar Jason Locasale, Ph.D.
July 06, 2022 08:00 ET
|
Cornerstone Pharmaceuticals, Inc.
CRANBURY, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer therapeutics and formerly known as Rafael...
Global Microbiome Market Report 2022: A $10+ Billion Market by 2026 - Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F
June 20, 2022 04:13 ET
|
Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Report 2022: By Type, By Application, By Technology" report has been added to ResearchAndMarkets.com's offering. The global...
Global Metabolomics Services Market Trends and Forecast Report 2022-2035, Featuring Profiles of Creative Proteomics, DNA Xperts, Metabo Profile, Metabolon and Synbio Technologies
May 11, 2022 05:13 ET
|
Research and Markets
Dublin, May 11, 2022 (GLOBE NEWSWIRE) -- The "Metabolomics Services Market by Area of Application, Type of Metabolomics Service Offered, Type of Metabolome Profiling Technique Used, Type of End User...
Worldwide Monoclonal Antibodies Industry to 2028 - Rising Prevalence of Cancer and Other Chronic Diseases are Driving Growth
February 25, 2022 07:58 ET
|
Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source, Production Method, Indication, Application, and...
Metabolon Announces Chief Financial Officer Transition
February 14, 2022 08:37 ET
|
Metabolon
MORRISVILLE, N.C., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announces the appointment of Gerald M. Haines II as Chief Financial Officer (CFO), as current...
World Microbiome Market Research Report 2021: Technology Enablers Facilitating Adoption
January 26, 2022 05:38 ET
|
Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Technology Enablers Facilitating Microbiome Adoption in Research and Development" report has been added to ResearchAndMarkets.com's offering. This...
Global Mass Spectrometry Market by Technology and Application Report 2021-2030: Miniaturization of Mass Spectroscopy Devices and Untapped Emerging Markets Creates Opportunities
January 26, 2022 04:28 ET
|
Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Mass Spectrometry Market by Technology and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
The Global Cell Lysis & Disruption Market Size is Expected to Reach USD 8.37 Billion by 2028, Registering a CAGR of 9.35% Over the Forecast Period
December 30, 2021 06:18 ET
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Lysis & Disruption Market Size, Share & Trends Analysis Report by Application (Protein Isolation, Downstream Processing), by Cell...
Global Metabolomics Market Research Report 2021 Featuring Major Players Such as Human Metabolome Technologies, Metabolon, Bio-Rad Laboratories, Bruker & Agilent Technologies - Forecasts to 2025 & 2030
December 13, 2021 07:08 ET
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Metabolomics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...